In contrast, immune checkpoint inhibitors (ICIs) targeting PD-1/PD-L1 have shown promising activity in UPS-ST but minimal efficacy in osteosarcoma, leaving the role of ICIs in UPS-B largely unknown. The gene discussed is CD274; the disease is osteosarcoma.